Cargando…
Development and Validation of Pretreatment Serum Total Bilirubin as a Biomarker to Predict the Clinical Outcomes in Primary Central Nervous System Lymphoma: A Multicenter Cohort Study
SIMPLE SUMMARY: The prognosis of patients with primary central nervous system lymphoma (PCNSL) is poor due to the high recurrence rate and lack of consensus on the optimal treatment for refractory or relapsed diseases. Despite having good prognostic scores, such as an MSKCC score or IELSG score, non...
Autores principales: | Cao, Jiazhen, Li, Shengjie, Li, Danhui, Hua, Wei, Guo, Lin, Xia, Zuguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526312/ https://www.ncbi.nlm.nih.gov/pubmed/37760555 http://dx.doi.org/10.3390/cancers15184584 |
Ejemplares similares
-
Proposed new prognostic model using the systemic immune-inflammation index for primary central nervous system lymphoma: A prospective-retrospective multicohort analysis
por: Li, Shengjie, et al.
Publicado: (2022) -
Validation of a transcutaneous bilirubin meter in Mongolian neonates: comparison with total serum bilirubin
por: Akahira-Azuma, Moe, et al.
Publicado: (2013) -
Increased serum total bilirubin-albumin ratio was associated with bilirubin encephalopathy in neonates
por: Wang, Yan, et al.
Publicado: (2020) -
A nomogram based on pretreatment levels of serum bilirubin and total bile acid levels predicts survival in colorectal cancer patients
por: Cao, Yinghao, et al.
Publicado: (2021) -
Pretreatment diffusion-weighted imaging for prediction of relapsed and refractory primary central nervous system lymphoma
por: Chien, Hsi-Cheng, et al.
Publicado: (2023)